Drug Shortage Report for VISTITAN
| Report ID | 238948 |
| Drug Identification Number | 02429063 |
| Brand name | VISTITAN |
| Common or Proper name | VISTITAN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | BIMATOPROST |
| Strength(s) | 0.03% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01EE |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-09-30 |
| Estimated end date | 2024-10-11 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-10-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-10-01 | English | Compare |
| v3 | 2024-09-30 | French | Compare |
| v2 | 2024-09-30 | English | Compare |
| v1 | 2024-09-30 | English | Compare |
Showing 1 to 4 of 4